Dynamics of mature myelin

LA Osso, EG Hughes - Nature neuroscience, 2024‏ - nature.com
Myelin, which is produced by oligodendrocytes, insulates axons to facilitate rapid and
efficient action potential propagation in the central nervous system. Traditionally viewed as a …

MWF of the corpus callosum is a robust measure of remyelination: Results from the ReBUILD trial

E Caverzasi, N Papinutto, C Cordano, G Kirkish… - Proceedings of the …, 2023‏ - pnas.org
Myelin repair is an unrealized therapeutic goal in the treatment of multiple sclerosis (MS).
Uncertainty remains about the optimal techniques for assessing therapeutic efficacy and …

Targeting the muscarinic M1 receptor with a selective, brain-penetrant antagonist to promote remyelination in multiple sclerosis

MM Poon, KI Lorrain, KJ Stebbins, GC Edu… - Proceedings of the …, 2024‏ - pnas.org
Multiple sclerosis (MS) is a chronic and debilitating neurological disease that results in
inflammatory demyelination. While endogenous remyelination helps to recover function, this …

Targeting cell membranes, depleting ROS by dithiane and thioketal-containing polymers with pendant cholesterols delivering necrostatin-1 for glaucoma treatment

R Rong, X Zhou, G Liang, H Li, M You, Z Liang… - ACS …, 2022‏ - ACS Publications
Glaucoma is the leading cause of irreversible blindness worldwide, characterized by
progressive vision loss due to the selective damage to retinal ganglion cells (RGCs) and …

Remyelination in animal models of multiple sclerosis: finding the elusive grail of regeneration

D Packer, EE Fresenko, EP Harrington - Frontiers in Molecular …, 2023‏ - frontiersin.org
Remyelination biology and the therapeutic potential of restoring myelin sheaths to prevent
neurodegeneration and disability in multiple sclerosis (MS) has made considerable gains …

Synaptic injury in the inner plexiform layer of the retina is associated with progression in multiple sclerosis

C Cordano, S Werneburg, A Abdelhak, DJ Bennett… - Cell Reports …, 2024‏ - cell.com
While neurodegeneration underlies the pathological basis for permanent disability in
multiple sclerosis (MS), predictive biomarkers for progression are lacking. Using an animal …

Remyelination protects neurons from DLK-mediated neurodegeneration

GJ Duncan, SD Ingram, K Emberley, J Hill… - Nature …, 2024‏ - nature.com
Chronic demyelination and oligodendrocyte loss deprive neurons of crucial support. It is the
degeneration of neurons and their connections that drives progressive disability in …

Incomplete remyelination via therapeutically enhanced oligodendrogenesis is sufficient to recover visual cortical function

G Della-Flora Nunes, LA Osso, JA Haynes… - Nature …, 2025‏ - nature.com
Myelin loss induces neural dysfunction and contributes to the pathophysiology of
neurodegenerative diseases, injury conditions, and aging. Because remyelination is often …

Prolonged myelin deficits contribute to neuron loss and functional impairments after ischaemic stroke

YJ Cheng, F Wang, J Feng, B Yu, B Wang, Q Gao… - Brain, 2024‏ - academic.oup.com
Ischaemic stroke causes neuron loss and long-term functional deficits. Unfortunately,
effective approaches to preserving neurons and promoting functional recovery remain …

Discovery of a brain penetrant small molecule antagonist targeting LPA1 receptors to reduce neuroinflammation and promote remyelination in multiple sclerosis

MM Poon, KI Lorrain, KJ Stebbins, GC Edu… - Scientific Reports, 2024‏ - nature.com
Multiple sclerosis (MS) is a chronic neurological disease characterized by inflammatory
demyelination that disrupts neuronal transmission resulting in neurodegeneration …